KeyCare Deploys NVIDIA Nemotron to Power AI-Driven Clinical Intake at Scale

Clinician-validated AI intake reduces documentation burden and improves virtual care efficiency  

Chicago, IL, March 24, 2026, KeyCare, the only national Epic-based virtual care group, today announced the deployment of NVIDIA’s Nemotron large language model in production to power its AI-driven patient intake agent. KeyCare selected Nemotron for its strong reasoning performance, consistency, and suitability for real-world clinical workflows.  

KeyCare’s Intake Agent, which is embedded in KeyCare’s virtual waiting room, adapts in real time based on the patient’s reason for visit, summarizing clinically relevant information in Epic before the encounter begins. Patients engage with the agent while waiting, enabling clinicians to focus their time on assessment and care. The solution is live across KeyCare’s clinical operations and is delivering measurable improvements in provider efficiency and the visit experience. For common urgent care visits such as upper respiratory infections and urinary tract infections, early results show a 15–30% improvement in provider efficiency when the agent is used. KeyCare continues to refine the intake agent across additional highvolume conditions.  

“At most virtual care organizations, clinicians still do the majority of intake and documentation themselves, or rely on medical assistants to conduct intake,” said KeyCare’s   Chief Medical Officer Carrie Nelson, MD. “By using technology, we’re shifting that work to an AI agent that clinicians trust, freeing them to focus on care rather than data entry.”  

Clinicians using the system report faster visits, clearer patient context, and reduced cognitive load. A few clinician comments include:

“I really love having the summary on why patients are coming in. It captures their symptoms, and often I can quickly decipher the reason for the visit, which helps direct the conversation. This definitely makes me more efficient.”  

“This is a useful tool to summarize a patient’s concerns and focus the discussion. I find that patients appreciate when I have done a little digging in their chart for context and can lead with a brief summary.”  

Unlike traditional telehealth platforms that bolt AI onto existing workflows, KeyCare operates a vertically integrated model that combines technology, clinical operations, and a   50-state medical group. This structure allows AI agents like the intake agent, to be deployed safely in production, governed appropriately, and scaled across health system partners.

In addition to building its own AI agents, KeyCare’s Epic-native foundation also positions the company to rapidly adopt and operationalize AI innovations emerging from Epic, as well as third-party solutions built to integrate with the Epic ecosystem. This ensures new AI capabilities can be delivered directly within clinician workflows rather than as   disconnected tools.  

“Our goal is not to experiment with AI in healthcare, it’s to operationalize it,” said Sulabh Agarwal, CEO at KeyCare. “NVIDIA Nemotron enables us to deliver AI that clinicians rely on every day, not just in demos.”  

KeyCare plans to expand its use of NVIDIA-powered AI agents across additional parts of the virtual care workflow, including visit routing, operational optimization, and patient support.